3 ms·
http://slatestarcodex.com/2016/09/07/reverse-voxsplaining-brand-name-drugs/ http://slatestarcodex.com/2016/09/07/reverse-voxsplaining-br...
by ikeboy 10y ago
http://slatestarcodex.com/2016/09/07/reverse-voxsplaining-brand-name-drugs/ http://slatestarcodex.com/2016/09/07/reverse-voxsplaining-br...
- HarryHirsch 10y agoThe vultures that trade in small-volume generics do innovation now? Turing and Valeant do R&D?! The bigger issue is the financing model that causes innovation to happen in all the wrong fields, but that is a different question and very complex.
- deleted 10y ago[deleted]
- therpe1 10y agoThat article is long and completely without substance. I don't know why I didn't turn back sooner but lesson learned. Anybody who thinks the drug industry charges so much for "innovation" is just dumb. Like all sellers the drug industry charges exactly what buyers are willing to pay. When the buyer is the federal government (and make no mistake, the federal government is indeed the biggest purchaser of healthcare and healthcare has been thoroughly "medicalized" [1][2]) then there's absolutely no limit to what you can charge. This situation thoroughly accounts for the high drug prices unique to the US and there is no need to crap out a bunch of words about innovation. [1] http://www.commonwealthfund.org/publications/newsletters/washington-health-policy-in-review/2016/dec/december-5-2016/federal-government-emerges-as-top-health-buyer http://www.commonwealthfund.org/publications/newsletters/was... [2] https://en.wikipedia.org/wiki/Health_care_finance_in_the_United_States#Role_of_government_in_health_care_market https://en.wikipedia.org/wiki/Health_care_finance_in_the_Uni...